CRINETICS PHARMACEUTICALS IN

CRINETICS PHARMACEUTICALS IN: CFO Insider Buy Signals Strong Pipeline Growth

CRINETICS PHARMACEUTICALS insiders buy shares amid bullish run, boosting confidence in its endocrine‑oncology pipeline and upcoming data releases.

CRINETICS PHARMACEUTICALS IN
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

24/08/2026, 23:14

4 minutes to read

CEO Richard Scott’s Big Buy Signals Confidence in CRINETICS’ Biotech Pipeline

CEO Richard Scott’s recent bulk buy of CRINETICS stock signals strong confidence in the company’s oncology pipeline and may spark renewed investor interest.

CRINETICS PHARMACEUTICALS IN
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

11/08/2026, 22:31

4 minutes to read

CRINETICS Insider Sale: Okey Stephanie Sells 6,900 Shares Near $35.70

CRINETICS insider sale: Okey Stephanie sells 6,900 shares, a routine 53% divestment at ~$35.60—no crash, just portfolio rebalancing. Watch future clinical wins and investor flow.

CRINETICS PHARMACEUTICALS IN
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

18/06/2026, 23:39

3 minutes to read